Vimarsana
Biggest News Aggregation in the World

Discussion Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Discussion Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Discussion Date Today - Breaking & Trending Today

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 - Vimarsana News

Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

Published: June 3, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Source: prnewswire.com
Related Topics:
United StatesChunlei LiValerie Malyvanh JansenYakun WangElevation Oncology IncCorporate Communications Investor RelationsAmerican Society Of Clinical OncologyPrnewswire Elevation Oncology IncExchange CommissionGroup LimitedDrug AdministrationAmerican SocietyClinical OncologyChief Medical OfficerElevation OncologyChief Scientific OfficerPoster DiscussionMolecularly Targeted AgentsSession DateDiscussion DateInvestigational New DrugPrivate Securities Litigation Reform ActOncology InvestorCorporate Communications
Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 - Vimarsana News

Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023

Published: April 26, 2023

/PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies...

Source: prnewswire.com
Related Topics:
United StatesValerie Malyvanh JansenYakun WangCorporate Communications Investor RelationsElevation Oncology IncGroup LimitedDrug AdministrationAmerican Society Of Clinical OncologyPrnewswire Elevation Oncology IncExchange CommissionAmerican SocietyClinical OncologyElevation OncologyChief Medical OfficerPoster DiscussionMolecularly Targeted AgentsSession DateDiscussion DateInvestigational New DrugPrivate Securities Litigation Reform ActOncology InvestorCorporate Communications